A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra- abdominal infections

Archives of Surgery

Volumn 132, Issue 12, 1997, Pages 1294-1302

  Barie, Philip S ^a   Vogel, Stephen B ^b   Dellinger, E Patchen ^c   Rotstein, Ori D ^d   Solomkin, Joseph S ^e   Yang, Joanna Y ^f   Baumgartner, Todd F ^f  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CINCINNATI   (United States)

^f BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CILASTATIN PLUS IMIPENEM; METRONIDAZOLE;

ABDOMINAL INFECTION; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL INFECTION; SURGICAL PATIENT; TREATMENT OUTCOME; VOMITING;

EID: 0031467601     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430360040008     Document Type: Article

References (23)

1. Mosdell DM, Morris DM, Voltura A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 1991;214:543-549.
2. Barie PS, Christou NV, Dellinger EP, et al. Pathogenicity of the enterococcus in surgical infections. Ann Surg. 1990;212:155-159.
3. Barie PS. Emerging problems in gram-positive infections in the postoperative patient. Surg Gynecol Obstet 1993;177(suppl):S55-S64.
4. Burnett RJ, Haverstock DC, Dellinger EP, et al. Definition ot the role of enterococcus in infra-abdominal infection. Surgery. 1995;118:716-721.
5. Solomkin JS, Dellinger EP, Christou NV, et al. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg. 1990;212:581-591.
6. Buckley MM, Brogden RM, Barradell LB, et al. Imipenem/cilastatin: a reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic effect. Drugs. 1992;44:404-408.
7. Solomkin JS, Reinhart HH, Dellinger EP, et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. Ann Surg. 1996;233:303-315.
8. Thornsberry C, Yee YC. Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods. Am J Med. 1996;100(suppl 6A):265-385.
9. Okamoto MP, Chin M, Gill MA, et al. Analysis of cefepime tissue penetration into human appendix. Pharmacotherapy. 1991;11:353-358.
10. Solomkin JS, Hemsell DL, Sweet R, et al. General guidelines for evaluation of new anti-infective drugs for the treatment of intra-abdominal and pelvic infections. Clin Infect Dis. 1992;15(suppl 1):S33-S42.
11. Knaus WA, Draper EA, Wagner DP, et al. APACHE II. Crit Care Med. 1985;13: 818-829.
12. Solomkin JS, Hemsell DL, Sweet R, et al. General guidelines for the evaluation of new anti-infective drugs for the treatment of intra-abdominal infections. In: Beam TR, Gibert DN, Kunin CM, eds. European Guidelines for the Clinical Evaluation of Anti-infective Drug Products 1993. Brussels, Belgium: European Society of Clinical Microbiology and Infectious Disease; 1993.
13. Lohmann C, Whitman DM, Watch A, and the Peritonitis Study Group. Prospective evaluation of prognostic scoring systems in peritonitis. Eur J Surg. 1993; 159:267-274.
14. Levison MA, Ziegler D. Correlation of APACHE II score, drainage technique, and outcome in postoperative intra-abdominal abscess. Surg Gynecol Obstet. 1991; 172:89-94.
15. Schein M, Gecelter G, Freinkel Z, Gerding H. APACHE II in emergency operation for perforated ulcers. Am J Surg. 1990;159:309-313.
16. Barie PS, Hydo LJ, Fischer E. Predictive value of APACHE seventy scoring for the development of multiple organ dysfunction syndrome in critically ill patients with perforated viscus. Arch Surg. 1996;131:37-43.
17. Bohnen JM, Mustard RA, Oxholm SE, Schouten BD. APACHE II score and abdominal sepsis: a prospective study. Arch Surg. 1988;123:225-229.
18. Barie PS, Hydo L, Fischer E. Comparison of APACHE II and III scoring systems for mortality prediction in critical surgical illness. Arch Surg. 1995;130:77-82.
19. Christou NV, Barie PS, Dellinger EP, et al. Surgical Infection Society Intra-abdominal Infection Study. Arch Surg. 1993;128:193-199.
20. Weigelt JA, Easley SM, Thal ER, et al. Abdominal surgical wound infection is lowered with improved perioperative Enterococcus and Bacteroides therapy. J Trauma. 1993;34:579-584.
21. Christou NV, Turgeon P, Wassef R, et al. Management of intra-abdominal infections. Arch Surg. 1996;131:1193-1201.
22. Brismar B, Malmborg AS, Tunevall G, et al. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrob Agents Chemother. 1992;36:2765-2773.
23. Wise R, Donovan IA, Lockley MR, et al. The pharmacokinetics and tissue penetration of imipenem. J Antimicrob Chemother. 1986;18(suppl E):93-101.